1. Optimizing API Production as a True Manufacturing Partner

    Jim Scandura, Executive Vice President, Chief Operating Officer at Avara Pharmaceutical Service discusses serving as a partner for API production.

  2. Meeting Customer Needs
    James E. Gregory, President and CEO of UPM Pharmaceuticals explains how to adapt to client expectations.
  3. Providing a Complete Modular Solution
    George Wiker, Executive Director at AES, explains the company's complete in-house offering.
  4. ZUMA-1 Study of Yescarta Reports 58% Complete Remission

    Long-term data presented at the American Society of Hematology Annual Meeting.

  5. Phase II Results Reveal High-Performance Immunotherapy

    RA drug nearly eliminates Graft-Versus-Host disease.

  6. Emerging Lyme Disease Tests Found Efficacious

    Expert multidisciplinary team finds next-gen diagnostics ready for clinicians. 

  7. Transforming the Pharmaceutical Industry Pipeline with In Silico Approaches
    Icagen Inc. explains supporting an in silico drug discovery program.
  8. Big Data: A Big Challenge

    There is almost no aspect of the life sciences and related industries that Big Data cannot impact.

  9. BIO World Congress on Industrial Biotechnology Announces Call for Presentations

    The Biotechnology Innovation Organization (BIO) today issued a call for presentations for the 2018 BIO World Congress on Industrial Biotechnology. 

  10. CRB on the Road to BIO: Making Your Facility a Future Facility
    Matthew Kennedy, Process Specialist, Senior Associate at CRB comments on overcoming challenges for clients, including investment uncertainty.
  11. Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach

    Andrew Harris, Associate, Lead Process Engineer and Joe Povenski, Process Specialist for CRB USA explain maintaining facilities.

  12. Sustainable Strategies for Contract Development and Manufacturing Service Growth

    Members of the “Who’s Who” of CMO/CDMO leadership are pursuing robust growth strategies to keep the CDMO segment energized and interesting. 

  13. Genentech and Biothera to Assess Combination Cancer Therapy

    Genentech to conduct trial to assess two of its antibodies with Biothera’s Imprime PPG for the treatment of metastatic colorectal cancer.

  14. Vetter Begins Construction of Packaging Facility Expansion
    New capabilities are being added to meet the growing need for complex packaging solutions.
  15. Generic Firms Developing Opioids with Abuse-Deterrent Properties Have New FDA Guidance to Follow
    Guidance is specifically for companies submitting ANDAs for generic solid oral opioid drug products.
  16. Men in the UK Will Be Able to Buy Viagra Over the Counter Next May

    Viagra reclassified as an over-the-counter medicine.

  17. No Clinically Meaningful Difference: The Upward Trend of Biosimilars

    Following a string of approvals, biosimilars are positioned to go the way of generics.

  18. Moving Beyond Monoclonal Antibodies
    Next-generation antibody therapeutics are designed to provide improved specificity, efficacy and safety when compared to conventional monoclonal antibodies.
  19. Pharma’s Automation Index on the Rise
    Call it the automation of everything — a hands-off approach will permeate supply chains in the near future.
  20. Holiday Program Brings Hope Home to Lung Cancer Patients

    Volunteers wrap presents, decorate trees, sing carols, hang outdoor holiday lights, write cards and bring much needed help to lung cancer patients throughout the country.

Nice Insight Research
CDMO
Annual Study
A study of 163 CDMOs for use by both buyers and sellers of contract services with customer ratings
702 Respondents
313 Profiles
163 Deepdive
View Directory
CRO
Annual Study
Compare ratings for 73 CROs and clinical services providers to match buyer or seller needs
609 Respondents
124 Profiles
73 Deepdive
View Directory
Excipients
Annual Study
Learn customer needs directly from 541 respondents to ensure you meet them and gain sales
541 Respondents
39 Profiles
31 Deepdive
View Directory
OEM
Annual Study
Find out the most important factors in equipment purchasing from 597 customers for the year for (bio)processing
597 Respondents
137 Profiles
90 Deepdive
View Directory
Clinical Supply
Chain Annual Study
320 customers rate key factors in supporting an emerging global clinical supply chain model
320 Respondents
22 Profiles
22 Deepdive
View Directory
Intermediates
Annual Study
545 buyers reveal key factors in sourcing and purchasing pharmaceutical intermediates
545 Respondents
86 Profiles
62 Deepdive
View Directory
MOST VIEWED THIS MONTH
Pharma's Almanac TV
View All Video

Road To BIO: Coming Soon To Your Screen

That’s Nice is producing a film based on the Road To BIO, for release in 2017. Watch the teaser trailer to get a taster of all the behind-the-scenes stories, character insights, and what went into the project.

Facility Expansion at Abzena

John Manzello, President, US, Abzena

Attracting Investors and Shortening Development Times

James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)

Providing a Complete Modular Solution

George Wiker, Executive Director, AES

Bringing Bioscience to Space

Bill Goodman, Ph.D., Vice President, SCORPIO-V, a Division of HNu Photonics
Devin Ridgley, Project Scientist, SCORPIO-V, a Division of HNu Photonics

Hemophilia

Results of New Gene Therapy Revealed at Hemophilia Meeting

Dec 12, 2017 1:27:27 PM PAO-M12-17-NI-017
Drug Development

ZUMA-1 Study of Yescarta Reports 58% Complete Remission

Dec 12, 2017 1:24:23 PM PAO-M12-17-NI-016
Immunotherapy

Phase II Results Reveal High-Performance Immunotherapy

Dec 12, 2017 1:21:40 PM PAO-M12-17-NI-015
Diagnostics

Emerging Lyme Disease Tests Found Efficacious

Dec 12, 2017 1:06:56 PM PAO-M12-17-NI-014
Over-the-Counter

Men in the UK Will Be Able to Buy Viagra Over the Counter Next May

Dec 8, 2017 10:36:14 AM PAO-M12-17-NI-013
Packaging

Vetter Begins Construction of Packaging Facility Expansion

Dec 8, 2017 10:20:38 AM PAO-M12-17-NI-011
Immuno-oncology

Genentech and Biothera to Assess Combination Cancer Therapy

Dec 8, 2017 10:17:37 AM PAO-M12-17-NI-010
Innovation

University of Michigan Innovates with Kevlar Cartilage

Dec 7, 2017 3:30:14 PM PAO-M12-17-NI-009
Drug Development

U.S. Patient Receives Kite’s Yescarta CART-T Therapy

Dec 7, 2017 3:23:37 PM PAO-M12-17-NI-008
Biosimilars

First Biosimilar to Treat Breast and Stomach Cancers Approved

Dec 7, 2017 3:13:06 PM PAO-M12-17-NI-007
Medical Application

FDA Clears KardiaBand Apple Watch Heart Monitoring App

Dec 7, 2017 2:57:55 PM PAO-M12-17-NI-006
Mergers & Acquistions

Five Critical Considerations for Pharmaceutical M&A

Dec 7, 2017 1:11:25 PM PAO-M12-17-Cl-001
Strategic Partnership

AstraZeneca Launches Strategic Joint Venture in China

Dec 5, 2017 2:36:34 PM PAO-M12-17-NI-005
Clinical Trial

Zika Vaccine Candidate Enters Phase I Trial

Dec 5, 2017 2:35:41 PM PAO-M12-17-NI-008
Strategic Partnership

Russia’s BIOCAD to Manufacture Biosimilars in North Africa

Dec 5, 2017 2:23:38 PM PAO-M12-17-NI-007
Cell and Gene Therapy

Brammer Bio Completes Renovations at Manufacturing Site in Massachusetts

Dec 5, 2017 1:59:20 PM PAO-M12-17-NI-006
Strategic Partnership

New Collaboration Targets the Development of Oligonucleotides

Dec 1, 2017 10:17:21 AM PAO-M12-17-NI-002
PAO-M12-17-NI-001

Amerisource Bergen Expands in the US with Acquisition of H.D. Smith

Dec 1, 2017 10:01:21 AM PAO-M12-17-NI-001
Business

Bio-Rad Authorizes New $250 Million Share Repurchase Program

Nov 30, 2017 2:23:30 PM PR-M11-17-NI-017
Acquisition

Pharmaterials Acquired by Quotient Sciences

Nov 30, 2017 2:06:38 PM PAO-M11-17-NI-051
Research

Study Finds Less Teflon in Environment Leads to Less Brain Damage

Nov 30, 2017 11:11:43 AM PAO-M11-17-NI-052
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

Nov 30, 2017 10:56:18 AM PAO-M11-17-NI-050
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

Nov 30, 2017 10:48:22 AM PAO-M11-17-NI-049
FDA Approval

Advanced Follicular Lymphoma Treatment Approved

Nov 28, 2017 1:03:03 PM PAO-M11-17-NI-048
Expansion

Fresenius Kabi Plans $100 Million North Carolina Expansion

Nov 28, 2017 1:02:19 PM PAO-M11-17-NI-047
Biosimilars

Boehringer Ingelheim’s Adalimumab Biosimilar Wins First EU Approval

Nov 28, 2017 1:01:06 PM PAO-M11-17-NI-045
Gene Editing

Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems

Nov 28, 2017 1:00:19 PM PAO-M11-17-NI-046
Adherence

Digital Technology Makes It into Medicines

Nov 24, 2017 3:03:00 PM PAO-M11-17-NI-044
Gene Editing

More Gene Editing Technology Being Developed by Novartis

Nov 24, 2017 3:02:00 PM PAO-M11-17-NI-043
Partnership

Alcami to Produce Clinical Supplies of Darinaparsin for Solasia

Nov 24, 2017 3:01:00 PM PAO-M11-17-NI-042
Nanopharmaceuticals

Glycan-coated Gold Nanoparticles are Target of Nanofacturing Consortium

Nov 24, 2017 3:00:00 PM PAO-M11-17-NI-041
Cell and Gene Therapy

Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics

PAP-Q4-17-CL-004
API

Achieving Efficient Pharmaceutical Synthesis with Process Intensification

PAP-Q3-17-CL-003
Columns

Virtual Panel

ADCs: The Future of Biologic Drugs
The contract manufacturing market for antibody-drug conjugates has huge potential, but an extraordinary range of capabilities is essential to be in the game. We spoke to some of the players to find out all about ADCs.

Roundtable

Innovative Technologies

Design Logic

Marken: Stronger Than Ever
Now stronger than ever, Marken needed a bold visual direction to illustrate its expanding breadth of services and ongoing commitment to personalized medicine.
//Fix for text overflow in cards